97 results on '"Doherty, T. Mark"'
Search Results
2. Healthy ageing: Herpes zoster infection and the role of zoster vaccination
3. 1171. Follow-up of vaccine preventable disease hospitalisations in the ageing population: onset of chronic comorbidities
4. 1152. Quantifying the health equity related public health impact of national immunisation programmes
5. 1170. Follow-up of vaccine preventable disease hospitalisations in the ageing population: Loss of Independence
6. Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective
7. Response letter Re: The burden of seasonal influenza: improving vaccination coverage to mitigate morbidity and its impact on healthcare systems
8. Maintaining a ‘fit’ immune system: the role of vaccines
9. Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?
10. Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework
11. Unveiling the contributions of immunization for progressing towards Universal Health Coverage
12. Separating Latent and Acute Disease in the Diagnosis of Tuberculosis
13. Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes
14. Effect of vaccination on the use of antimicrobial agents: a systematic literature review
15. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations
16. Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review)
17. Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
18. Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion
19. Would immunization be the same without cross-reactivity?
20. Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: a cluster randomised trial in Indian neonates vaccinated with BCG
21. Vaccination programs for older adults in an era of demographic change
22. Maternal immunization: where are we now and how to move forward?
23. Challenges in adult vaccination
24. A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area
25. Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
26. BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome
27. Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis
28. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls
29. Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort study
30. Combination of Cytokine Responses Indicative of Latent TB and Active TB in Malawian Adults
31. Expression of TNF-Alpha-Dependent Apoptosis-Related Genes in the Peripheral Blood of Malagasy Subjects with Tuberculosis
32. Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
33. Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth
34. Immunotherapy for TB
35. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting
36. Correction: Modulation of Transcriptional and Inflammatory Responses in Murine Macrophages by the Mycobacterium tuberculosis Mammalian Cell Entry (Mce) 1 Complex
37. Modulation of Transcriptional and Inflammatory Responses in Murine Macrophages by the Mycobacterium tuberculosis Mammalian Cell Entry (Mce) 1 Complex
38. Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection
39. Modulation of Cell Death byM. tuberculosisas a Strategy for Pathogen Survival
40. First in humans: A new molecularly defined vaccine shows excellent safety and strong induction of long-livedMycobacterium tuberculosis-specific Th1-cell like responses
41. Separating latent and acute TB
42. Immunodiagnosis of tuberculosis: new questions, new tools conference 2008
43. Heparin-binding, Hemagglutinin-specific IFN-γ Synthesis at the Site of Infection during Active Tuberculosis in Humans
44. Variation in Gamma Interferon Responses to Different Infecting Strains of Mycobacterium tuberculosis in Acid-Fast Bacillus Smear-Positive Patients and Household Contacts in Antananarivo, Madagascar
45. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
46. Tuberculin Skin Test and In Vitro Assays Provide Complementary Measures of Antimycobacterial Immunity in Children and Adolescents
47. Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
48. Comparison of different standards for real-time PCR-based absolute quantification
49. Biomarkers for tuberculosis disease activity, cure, and relapse
50. Biomarkers for tuberculosis disease activity, cure, and relapse – Authors' reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.